Shanghai Haohai Biological Technology Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
259.00
504.00
561.00
270.00
458.00
288.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
16.00
154.00
84.00
-195.00
0.00
58.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
699.00
764.00
739.00
329.00
588.00
461.00
Cash Flow from Investing Activities
-12.00
-475.00
-726.00
-852.00
-413.00
189.00
Cash Flow from Financing Activities
-567.00
-411.00
-13.00
-336.00
-219.00
-213.00
Net Cash Inflow / Outflow
125.00
-119.00
11.00
-842.00
-53.00
430.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
5.00
3.00
11.00
16.00
-8.00
-6.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shanghai Haohai Biological Technology Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
259.456560927568
111.868585690039
148.00
131.93%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
16.5916463572831
-1169.50987562256
1,185.00
101.42%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
699.734623118608
-1060.38621858382
1,759.00
165.99%
Cash Flow from Investing Activities
-12.0388863094377
-1343.67890634376
1,331.00
99.10%
Cash Flow from Financing Activities
-567.463789074055
967.097687281004
-1,534.00
-158.68%
Net Cash Inflow / Outflow
125.25404146427
-1419.69965653794
1,544.00
108.82%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
5.022093729154
17.2677811086456
-12.00
-70.92%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -8.42% vs 3.34% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
699.73
764.06
-8.42%






